147 related articles for article (PubMed ID: 15760056)
1. Tablet formulation containing meloxicam and beta-cyclodextrin: mechanical characterization and bioavailability evaluation.
Ghorab MM; Abdel-Salam HM; El-Sayad MA; Mekhel MM
AAPS PharmSciTech; 2004 Jul; 5(4):e59. PubMed ID: 15760056
[TBL] [Abstract][Full Text] [Related]
2. Tablet formulation studies on nimesulide and meloxicam-cyclodextrin binary systems.
Nalluri BN; Chowdary KP; Murthy KV; Becket G; Crooks PA
AAPS PharmSciTech; 2007 May; 8(2):Article 36. PubMed ID: 17622114
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of fast-dissolving tablets of meloxicam-β-cyclodextrin complex prepared by direct compression.
Obaidat AA; Obaidat RM
Acta Pharm; 2011 Mar; 61(1):83-91. PubMed ID: 21406346
[TBL] [Abstract][Full Text] [Related]
4. An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin.
Bandarkar FS; Vavia PR
Drug Dev Ind Pharm; 2011 Nov; 37(11):1318-28. PubMed ID: 21506882
[TBL] [Abstract][Full Text] [Related]
5. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
Patel NV; Chotai NP; Patel MP
Pharmazie; 2008 Apr; 63(4):275-81. PubMed ID: 18468386
[TBL] [Abstract][Full Text] [Related]
6. Development of meloxicam formulations utilizing ternary complexation for solubility enhancement.
Awasthi SS; Kumar TG; Manisha P; Preeti Y; Kumar SS
Pak J Pharm Sci; 2011 Oct; 24(4):533-8. PubMed ID: 21959817
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: influence of gastrointestinal dysfunction on the relative bioavailability of two formulations.
Aghazadeh-Habashi A; Jamali F
Eur J Pharm Biopharm; 2008 Nov; 70(3):889-94. PubMed ID: 18715548
[TBL] [Abstract][Full Text] [Related]
8. Adsorption of meloxicam on porous calcium silicate: characterization and tablet formulation.
Sharma S; Sher P; Badve S; Pawar AP
AAPS PharmSciTech; 2005 Dec; 6(4):E618-25. PubMed ID: 16408863
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-beta-cyclodextrin.
Taneri F; Ozcan I; Guneri T
Drug Deliv; 2010 Apr; 17(3):152-7. PubMed ID: 20148713
[TBL] [Abstract][Full Text] [Related]
10. Meloxicam β-cyclodextrin transdermal gel: physicochemical characterization and in vitro dissolution and diffusion studies.
Rasool BK; Gareeb RH; Fahmy SA; Rasool AA
Curr Drug Deliv; 2011 Jul; 8(4):381-91. PubMed ID: 21453259
[TBL] [Abstract][Full Text] [Related]
11. Preparation of meloxicam-β-cyclodextrin-polyethylene glycol 6000 ternary system: characterization, in vitro and in vivo bioavailability.
Radia O; Rogalska E; Moulay-Hassane G
Pharm Dev Technol; 2012; 17(5):632-7. PubMed ID: 21428700
[TBL] [Abstract][Full Text] [Related]
12. Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer.
Patel MM; Amin AF
Drug Deliv; 2011 May; 18(4):281-93. PubMed ID: 21138335
[TBL] [Abstract][Full Text] [Related]
13. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and bioequivalence study of meloxicam tablets in healthy male subjects.
Gschwend MH; Erenmemişoğlu A; Martin W; Tamur U; Kanzik I; Hincal AA
Arzneimittelforschung; 2007; 57(5):264-8. PubMed ID: 17598697
[TBL] [Abstract][Full Text] [Related]
15. A pilot human pharmacokinetic study and influence of formulation factors on orodispersible tablet incorporating meloxicam solid dispersion using factorial design.
Aboelwafa AA; Fahmy RH
Pharm Dev Technol; 2012; 17(1):1-14. PubMed ID: 20550483
[TBL] [Abstract][Full Text] [Related]
16. Studies on formulation development of mouth dissolving tablets of Carvedilol.
Pokharkar V; Dhar S; Mandpe L
Hindustan Antibiot Bull; 2007 Feb-2008 Nov; 49-50(1-4):21-8. PubMed ID: 19957540
[TBL] [Abstract][Full Text] [Related]
17. Elastic liposomes bearing meloxicam-beta-cyclodextrin for transdermal delivery.
Jain SK; Gupta Y; Jain A; Amin S
Curr Drug Deliv; 2008 Jul; 5(3):207-14. PubMed ID: 18673264
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence study of two brands of meloxicam tablets in healthy human Pakistani male subjects.
Ahmad M; Murtaza G; Akhtar N; Siddique F; Khan SA
Acta Pol Pharm; 2011; 68(1):115-9. PubMed ID: 21485709
[TBL] [Abstract][Full Text] [Related]
19. Characterization of ternary complexes of meloxicam-HPbetaCD and PVP or L-arginine prepared by the spray-drying technique.
El-Maradny HA; Mortada SA; Kamel OA; Hikal AH
Acta Pharm; 2008 Dec; 58(4):455-66. PubMed ID: 19103579
[TBL] [Abstract][Full Text] [Related]
20. Improved absorption of meloxicam via salt formation with ethanolamines.
Han HK; Choi HK
Eur J Pharm Biopharm; 2007 Jan; 65(1):99-103. PubMed ID: 16919925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
